Forty years of sports performance research and little insight gained

Abstract:

Sports drinks manufacturers are keen to emphasise that their products are supported by science, although they are more reticent about the details. As part of the BMJ’s analysis of the evidence underpinning sports performance products, it asked manufacturers to supply details of the studies. Only one manufacturer, GlaxoSmithKline, complied. It provided us with a comprehensive bibliography of the trials used to underpin its product claims for Lucozade—a carbohydrate containing sports drink.1 Other manufacturers of leading sports drinks did not supply us with comprehensive bibliographies, and in the absence of systematic reviews we surmise that the methodological issues raised in this article could apply to all other sports drinks.

Of this list of 176 studies, we were able to critically review 106 studies (101 clinical trials) dating from 1971 through to 2012. We did not review posters, supplements, theses, or unavailable articles (see the linked data supplement).

Clinical trials are the best study design we have to evaluate what effect a “treatment”—in this case Lucozade sports drinks—will have on performance. However, not all trials are created equal,2 and the label of randomised controlled trial is no guarantee that a study will provide adequate or useful evidence. As it turns out, if you apply evidence based methods, 40 years of sports drinks research does not seemingly add up to much, particularly when applying the results to the general public. Below we set out the main problems we identified together with some examples.